Metatech (Ap) Inc.

Metatech (Ap) Inc.

TTPEX:3224
30.25
TWD
-0.55
(-1.79%)
-2.17EPS
2.46BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
62.05
63.1
53.66
41.12
32.58
25.15
24.09
27.17
33.17
27.17
21.22
20.73
22.23
22.06
Basic EPS, GAAP
0.17
0.56
0.04
-1.39
0.12
-0.99
-1.58
-1.42
-0.4
-0.17
-1.94
-1.01
-1.53
-0.46
Free Cash Flow per Basic Share
3.94
-1.1
-1.04
1.77
-2.56
-3.64
-3.68
-0.86
-3.59
-0.28
0.18
-9.16
-9.28
-10.29
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
8.21
9.17
12.16
10.94
13.47
18.29
17.12
15.6
18.9
19.29
17.35
16.78
15.08
17.86
Tangible Book Value per Share
8.21
9.17
11.62
10.94
13.16
15.96
12.72
10.86
14.93
15.44
14.44
13.98
12.4
15.59
Basic Weighted Avg Shares
34
32
40
40
44
58
59
58
61
68
68
68
68
80
Sales/Revenue/Turnover
2,128
2,043
2,153
1,663
1,429
1,460
1,413
1,576
2,012
1,852
1,446
1,412
1,515
1,755
Operating Margin (%)
0.15
0.77
-0.27
-3.38
0.8
-5.66
-8.2
-5.09
-1.79
-4.91
-13.34
-15.83
-15.26
-9.77
Depreciation Expense
5
4
5
10
6
7
34
37
47
46
51
57
65
68
Net Income, GAAP
6
18
2
-56
5
-58
-93
-82
-24
-12
-132
-69
-104
-37
Effective Tax Rate (%)
19.92
- -
74.76
- -
34.61
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
0.28
0.88
0.08
-3.38
0.36
-3.95
-6.56
-5.23
-1.2
-0.64
-9.12
-4.87
-6.88
-2.09
Working Capital
230
395
420
359
465
683
548
443
2,370
2,359
2,144
1,598
1,170
1,116
LT Debt
31
169
- -
- -
- -
- -
259
260
103
94
88
84
301
613
Total Equity
282
314
525
462
600
1,073
1,004
915
2,958
2,941
2,734
2,607
2,346
2,619
Return on Invested Capital (%)
0.53
- -
-0.27
- -
1.4
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
2.2
- -
0.51
- -
1.07
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
2.14
6.06
0.42
-11.39
0.98
-6.91
-8.93
-8.6
-2.19
-0.9
-10.57
-5.92
-9.61
-3.01

Capital Structure

TWD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
352
342
367
LT Borrowings
319
436
554
LT Finance Leases
64
63
59
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
78
78
78
Market Capitalization
3,282
2,950
2,457

Working Capital

TWD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
2,015
2,056
2,025
Cash, Cash Equivalents & STI
1,447
1,404
1,231
Accounts Receivable, Net
381
410
502
Inventories
85
119
151
Total Current Liabilities
587
641
909
Payables & Accruals
- -
- -
- -
ST Debt
352
342
367
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28.24%
40.2%
-10.03%
Free Cash Flow
-552.89%
-1,002.74%
1.3%
Net Income, GAAP
-367.52%
180.6%
51.49%
Sales/Revenue/Turnover
-2.37%
0.54%
7.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
330
333
414
336
1,412
2025
387
371
391
365
1,515
2026
410
417
563
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.37
-0.15
-0.18
-0.32
-1.01
2025
-0.2
-0.62
-0.24
-0.48
-1.53
2026
0.03
-0.11
0.02
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Hung Te Tang
Full Time Employees
51
Sector
Distribution services
Industry
Electronics distributors
Address
No. 75, Xintai 5th Road New Taipei TP Taiwan 22101
IPO Date
Jun 27, 2003
Business
MetaTech (AP) Inc. engages primarily in the wholesale and retail distribution of electronic products and components, including semiconductors, modules, and electronic materials, serving markets in Taiwan and internationally. The company offers a range of products such as high-quality monochrome liquid crystal displays (LCD), LCD modules (LCM), thin-film transistor (TFT), capacitive touch panels, and various board-level interconnecting devices under brands like Samtec. It also develops and manufactures cell sheets and cell therapy-related products, operating a biomedicine segment focused on regenerative medicine and cell and gene therapies. Additionally, MetaTech sells petri dishes and operates a tourism business. Founded in 1987, the company is headquartered in New Taipei City, Taiwan. In recent major developments, MetaTech has formed a strategic partnership with CM Plus Corporation from Japan to enhance business in biologics, regenerative medicine, and AI-driven GMP document generation technology, targeting markets in Taiwan, Japan, and broader Asia. This alliance supports the integration of MetaTech’s AI platform Neo-Katana with CM Plus’s regulatory and pharmaceutical expertise to establish a GMP AI ecosystem. The company also continues its expansion in regenerative medicine through its subsidiary Locus Cell, focusing on cell manufacturing for therapeutic use, leveraging patented M-Cell technology and AI innovations to improve production scaling and quality control. MetaTech’s joint ventures and collaborations reflect a major strategic shift towards biotechnology alongside its electronics distribution business. The company operates within the electronics and biomedical industries, serving sectors including telecommunications, consumer electronics, and healthcare, with geographical operations spanning Taiwan, Hong Kong, Mainland China, Southeast Asia, and Japan. MetaTech's product portfolio encompasses electronic components for industrial computers, servers, PC accessories, and wireless communication products. The company maintains a diversified business model with operations in both tech hardware distribution and cutting-edge regenerative medicine applications. MetaTech (AP) Inc. maintains its listing on the Taipei Exchange under ticker 3224.TWO, sustaining steady returns in the technology sector. It employs AI and digital transformation technology to drive innovation in cell therapy production and regulatory compliance, aligning with global healthcare trends and expanding its presence in biomedicine markets. The company’s governance and operational headquarters are based in Taiwan, supported by subsidiaries and partnerships that enhance its product offerings and market reach. Overall, MetaTech blends its foundational electronics distribution business with advanced biotechnology initiatives, positioning itself as a hybrid technology and biomedicine company focused on regional and international growth through innovation and strategic alliances.